Correlation Between Collplant Biotechnologies and Keros Therapeutics
Can any of the company-specific risk be diversified away by investing in both Collplant Biotechnologies and Keros Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Collplant Biotechnologies and Keros Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Collplant Biotechnologies and Keros Therapeutics, you can compare the effects of market volatilities on Collplant Biotechnologies and Keros Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Collplant Biotechnologies with a short position of Keros Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Collplant Biotechnologies and Keros Therapeutics.
Diversification Opportunities for Collplant Biotechnologies and Keros Therapeutics
-0.56 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Collplant and Keros is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Collplant Biotechnologies and Keros Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Keros Therapeutics and Collplant Biotechnologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Collplant Biotechnologies are associated (or correlated) with Keros Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Keros Therapeutics has no effect on the direction of Collplant Biotechnologies i.e., Collplant Biotechnologies and Keros Therapeutics go up and down completely randomly.
Pair Corralation between Collplant Biotechnologies and Keros Therapeutics
Given the investment horizon of 90 days Collplant Biotechnologies is expected to under-perform the Keros Therapeutics. In addition to that, Collplant Biotechnologies is 1.2 times more volatile than Keros Therapeutics. It trades about -0.02 of its total potential returns per unit of risk. Keros Therapeutics is currently generating about 0.02 per unit of volatility. If you would invest 4,943 in Keros Therapeutics on August 27, 2024 and sell it today you would earn a total of 649.00 from holding Keros Therapeutics or generate 13.13% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Collplant Biotechnologies vs. Keros Therapeutics
Performance |
| Timeline |
| Collplant Biotechnologies |
| Keros Therapeutics |
Collplant Biotechnologies and Keros Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Collplant Biotechnologies and Keros Therapeutics
The main advantage of trading using opposite Collplant Biotechnologies and Keros Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Collplant Biotechnologies position performs unexpectedly, Keros Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Keros Therapeutics will offset losses from the drop in Keros Therapeutics' long position.| Collplant Biotechnologies vs. Keros Therapeutics | Collplant Biotechnologies vs. Merus BV | Collplant Biotechnologies vs. Vericel Corp Ord | Collplant Biotechnologies vs. Century Therapeutics |
| Keros Therapeutics vs. Ideaya Biosciences | Keros Therapeutics vs. AnaptysBio | Keros Therapeutics vs. MeiraGTx Holdings PLC | Keros Therapeutics vs. Janux Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |